COMING SOON

Set the Standard

Distinction in Ig Therapy

Setting the Standard in Ig Therapy

 

Developed in collaboration with IgNS, the Distinction in Ig Therapy validates provider excellence in the delivery of immunoglobulin therapy. The distinction standards align the expertise of IgNS in clinician preparation and competencies with ACHC’s focus on quality and safety at the organizational level.

The result? A new step forward in improving quality, credibility, and patient outcomes in immunoglobulin therapy.

Discover More

Be the first to know when the Distinction in Ig Therapy launches.